Utility of pre-treatment neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as prognostic factors in breast cancer

被引:0
|
作者
C-H Koh
N Bhoo-Pathy
K-L Ng
R S Jabir
G-H Tan
M-H See
S Jamaris
N A Taib
机构
[1] Faculty of Medicine,Department of Surgery
[2] University of Malaya,Department of Surgery
[3] Hospital Tengku Ampuan Afzan,undefined
[4] Jalan Besar,undefined
[5] 25100 Kuantan,undefined
[6] Pahang,undefined
[7] Malaysia,undefined
[8] Julius Center University of Malaya,undefined
[9] Faculty of Medicine,undefined
[10] University of Malaya,undefined
[11] National Clinical Research Centre,undefined
[12] Hospital Kuala Lumpur,undefined
[13] Level 3,undefined
[14] Dermatology Block,undefined
[15] 50586 Jalan Pahang,undefined
[16] Kuala Lumpur,undefined
[17] Malaysia,undefined
[18] Julius Center for Health Sciences and Primary Care,undefined
[19] University Medical Center Utrecht,undefined
来源
British Journal of Cancer | 2015年 / 113卷
关键词
breast cancer; survival; neutrophil lymphocyte ratio; platelet lymphocyte ratio; Asia;
D O I
暂无
中图分类号
学科分类号
摘要
引用
下载
收藏
页码:150 / 158
页数:8
相关论文
共 50 条
  • [11] PROGNOSTIC SIGNIFICANT OF NEUTROPHIL: LYMPHOCYTE RATIO, PLATELET: LYMPHOCYTE RATIO, AND LYMPHOCYTE: MONOCYTE RATIO IN KURDISH PATIENTS WITH BREAST CANCER
    Khazaei, S.
    Tarlan, M.
    Madani, S. H.
    Jalilian, S.
    WORLD CANCER RESEARCH JOURNAL, 2022, 9
  • [12] COMMENT ON "PROGNOSTIC SIGNIFICANT OF NEUTROPHIL: LYMPHOCYTE RATIO, PLATELET - LYMPHOCYTE RATIO, AND LYMPHOCYTE: MONOCYTE RATIO IN KURDISH PATIENTS WITH BREAST CANCER"
    Pellicciaro, M.
    Berardi, S.
    Materazzo, M.
    Vanni, G.
    WORLD CANCER RESEARCH JOURNAL, 2022, 9
  • [13] Neutrophil lymphocyte ratio and platelet lymphocyte ratio as prognostic markers in ovarian cancer
    Singh, Nisha
    Rajput, Deepshikha
    Agrawal, Shuchi
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A202 - A203
  • [14] The prognostic role of pre-treatment neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy
    Man, Qirong
    Li, Peishun
    Fan, Jing
    Yang, Sen
    Xing, Chao
    Bai, Yunling
    Hu, Miaomiao
    Wang, Baohu
    Zhang, Kaixian
    BMC CANCER, 2024, 24 (01)
  • [15] Clinical significance of pre-operative neutrophil lymphocyte ratio and platelet lymphocyte ratio as prognostic factors for patients with colorectal cancer
    Zou, Zhen-Yu
    Liu, Hai-Liang
    Ning, Ning
    Li, Song-Yan
    Du, Xiao-Hui
    Li, Rong
    ONCOLOGY LETTERS, 2016, 11 (03) : 2241 - 2248
  • [16] Pre-treatment Peripheral Neutrophil-Lymphocyte Ratio as a Prognostic Marker in Gastric Cancer
    Magdy, Monika
    Hussein, Tarek
    Ezzat, Ahmed
    Gaballah, Ahmed
    JOURNAL OF GASTROINTESTINAL CANCER, 2019, 50 (04) : 763 - 768
  • [17] Pre-treatment Peripheral Neutrophil-Lymphocyte Ratio as a Prognostic Marker in Gastric Cancer
    Monika Magdy
    Tarek Hussein
    Ahmed Ezzat
    Ahmed Gaballah
    Journal of Gastrointestinal Cancer, 2019, 50 : 763 - 768
  • [18] Pre-treatment peripheral neutrophil-lymphocyte ratio as a prognostic factor in gastric cancer
    Gaballah, A.
    Hussein, T.
    Ezzat, A.
    Magdy, M.
    ANNALS OF ONCOLOGY, 2018, 29 : 15 - 15
  • [19] The Usefulness of the Pre-Operative Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Predicting Breast Cancer Recurrence
    Cullinane, C.
    McCumiskey, M.
    Lal, A.
    Merrigan, B. A.
    Tormey, S.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2018, 187 : S138 - S139
  • [20] Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic factors in locally advanced rectal cancer
    Duque-Santana, Victor
    Lopez-Campos, Fernando
    Martin-Martin, Margarita
    Valero, Mireia
    Zafra-Martin, Juan
    Counago, Felipe
    Sancho, Sonsoles
    ONCOLOGY, 2023, 101 (06) : 349 - 357